ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $184,933 | -4.5% | 91,100 | +8.2% | 0.00% | – |
Q2 2023 | $193,591 | +11.5% | 84,170 | +46.9% | 0.00% | – |
Q1 2023 | $173,619 | +51.8% | 57,300 | +16.7% | 0.00% | – |
Q4 2022 | $114,403 | +87.5% | 49,100 | +54.4% | 0.00% | – |
Q3 2022 | $61,000 | -7.6% | 31,800 | +31.4% | 0.00% | – |
Q2 2022 | $66,000 | +57.1% | 24,200 | +71.6% | 0.00% | – |
Q1 2022 | $42,000 | -23.6% | 14,100 | 0.0% | 0.00% | – |
Q4 2021 | $55,000 | -8.3% | 14,100 | 0.0% | 0.00% | – |
Q3 2021 | $60,000 | +39.5% | 14,100 | 0.0% | 0.00% | – |
Q2 2021 | $43,000 | -84.8% | 14,100 | -52.7% | 0.00% | – |
Q3 2018 | $282,000 | – | 29,821 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
Shay Capital LLC | 60,000 | $257,000 | 0.03% |
Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |